Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

PHASE4CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

July 6, 2024

Study Completion Date

November 5, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan

Potassium-competitive acid blocker

DRUG

Amoxicillin

Antibiotic for H. pylori eradication

Trial Locations (13)

Unknown

Changshu No.1 People's Hospital, Changshu

Changzhou Traditional Chinese Medicine Hospital, Changzhou

The first people's hospital of Lianyungang, Lianyungang

Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing

Nanjing First Hospital, Nanjing Medical University, Nanjing

Nanjing Jiangbei Hospital, Nanjing

Sir Run Run Hospital, Nanjing Medical University, Nanjing

Second Affiliated Hospital of Soochow University, Suzhou

Taixing People's Hospital, Taishing

The Fourth People's Hospital of Taizhou, Taizhou

The First People's Hospital of Xuzhou, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou

Affiliated Hospital of Yangzhou University, Yangzhou

The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER